Brief: IceCure Medical Receives Israeli Approval For Next-Gen XSense Cryoablation System For Breast Cancer, Other Indications
15/09/2025 13:52
Sept 15 (Reuters) - Icecure Medical Ltd ICCM.O: ICECURE MEDICAL LTD: RECEIVES ISRAELI APPROVAL FOR NEXT-GEN XSENSE™ CRYOABLATION SYSTEM FOR BREAST CANCER, OTHER INDICATIONS Source text: [ID:n0001213900-25-087437] Further company coverage: ICCM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Icecure Medical
See all newsIcecure Medical Ltd reports results for the quarter ended June 30 - Earnings Summary
Israel's IceCure Medical H1 revenue rises on higher system, probe sales
Brief: Icecure Sio Petitions Nccn To Include Cryoablation In Breast Cancer Treatment Guidelines, Citing Icecure's FDA Clearance Of Prosense®
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:45 AM